Psoriatic Arthritis
News
Early psoriatic arthritis treatment with etanercept gives better outcomes
Key clinical point: PsA treatment with etanercept within 2 years of diagnosis may lead to better patient-reported quality of life outcomes than...
News
Case series: Ustekinumab for psoriasis helps skin, hurts joints
Key clinical point: Increasing evidence suggests that ustekinumab is associated with discordant joint and skin responses. Major finding: Five of...
News
Framingham score underestimates CVD risk in psoriatic arthritis patients
Key clinical point: The Framingham Risk Score may not be applicable for estimating CVD risk in psoriatic arthritis patients. Major finding: The 10...
News
Annual costs of psoriasis costs top $112 billion
News
Immunogenicity to TNF-alpha blockers varies in psoriatic arthritis
Key clinical point: The use of methotrexate should be strongly considered in addition to TNF-alpha blockers in patients with psoriatic arthritis...
News
Psoriasis patients have higher rate of low back pain
Conference Coverage
Ixekizumab linked to decrease in psoriasis-related sexual difficulties
Key clinical point: Psoriasis patients have a high rate of sexual problems they attribute to their skin disease, and which decrease with effective...
Conference Coverage
Consider phototherapy for certain psoriasis patients
Conference Coverage
Oral tofacitinib scores against psoriasis in phase III trial
Key clinical point: Multiple measures of quality of life and disease burden improved similarly in psoriasis patients regardless of whether they...
Conference Coverage
Secukinumab tames psoriatic arthritis in FUTURE 2 trial
Key clinical point: Secukinumab could prove to be a major new therapy for psoriatic arthritis. Major finding: After 24 weeks, a response of at...
Conference Coverage
Few psoriatic arthritis patients achieve minimal disease activity on methotrexate
Key clinical point: It may be time to rethink methotrexate’s role as first-line therapy for psoriatic arthritis. Major finding: Only 17.4% of...